Endovia Health Sciences (EDVA) Cash from Investing Activities Growth (1y) (2016 - 2024)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Cash from Investing Activities Growth (1y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.06 Bn | 133.21 Bn | 2.84 Bn | 90.55% |
| 2 | Regeneron Pharmaceuticals | 86.96 Bn | 78.97 Bn | 3.93 Bn | 91.53% |
| 3 | Argenx Se | 64.93 Bn | 59.74 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.22 Bn | 52.08 Bn | 52.00 Mn | -41.67% |
| 5 | Revolution Medicines | 44.59 Bn | 44.59 Bn | - | - |
| 6 | BeOne Medicines | 40.43 Bn | 35.33 Bn | 1.53 Bn | 25.90% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | -157.08% |
| 8 | Royalty Pharma | 28.17 Bn | 27.34 Bn | - | 26.37% |
| 9 | Insmed | 27.60 Bn | 26.43 Bn | 358.27 Mn | -89.24% |
| 10 | Endovia Health Sciences | 821,701.01 | 578,999.01 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 173.46% |
| Dec 31, 2023 | 97.38% |
| Dec 31, 2020 | -23,230.69% |
| Sep 30, 2020 | 1.18% |
| Jun 30, 2020 | -3,675.19% |
| Mar 31, 2020 | -1,110.67% |
| Dec 31, 2019 | 91.31% |
| Sep 30, 2019 | 70.95% |
| Jun 30, 2019 | 118.05% |
| Mar 31, 2019 | 10.28% |
| Dec 31, 2018 | -595.51% |
| Sep 30, 2018 | -207.64% |
| Jun 30, 2018 | 38.19% |
| Mar 31, 2018 | 44.25% |
| Dec 31, 2017 | 68.79% |
| Sep 30, 2017 | 56.12% |
| Jun 30, 2017 | -203.83% |
| Mar 31, 2017 | 27.77% |
| Dec 31, 2016 | -30.31% |
| Sep 30, 2016 | -194.60% |